OFIX
Orthofix Medical Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$9.07Close
$361.3MMarket cap
$8.64 – $10.2452-week range
Nov 9, 2026Next report · before the open
Highlights
Cautions
- Results soon Nov 9, 2026, in 8 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
11%
1wk
down 7.5%
price change
1mo
down 3.6%
price change
12-month return
down 9%
total, dividends included
F-score
5 / 9
Mixed
Altman Z
0.93
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
0.8×
price / book
Earnings yield
down 18.6%
EBIT / enterprise value
Cheaper than
40%
of the market · around average
Revenue growth
up 3%
year on year
EPS growth
—
latest quarter
Sales growth
up 4%
latest quarter · +2 pts
ROE
down 19%
return on equity
Free cash margin
0%
-$1.3M FCF
D/E
0.35
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
- not yet profitable on its assets
- took on more long-term debt
- short-term liquidity weakened
- issued more shares
- generating cash from operations
- profitability improving
- profits backed by cash
- gross margin widened
- assets working harder
Trade setup
ATR%
4.9%
$0.44 a day · 2×ATR $8.18
RS
—
vs the universe
Trend
—
trend template
Relative volume
1.8×
vs 50-day average
Up/down volume
0.76
50 sessions
Implied move
—
no option chain · report Nov 9, 2026
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 3.5% over the year, from 38m to 40m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 5, 2026
Financials
- Gross 69%
- Net -11%
- Free cash -0%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M |
| Gross margin | 75% | 75% | 73% | 65% | 68% | 69% |
| Operating income | -$6.3M | -$8.3M | -$13.3M | -$139.1M | -$84.6M | -$81.4M |
| Net income | $2.5M | -$38.4M | -$19.8M | -$151.4M | -$126.0M | -$92.2M |
| Net margin | 1% | -8% | -4% | -20% | -16% | -11% |
| Earnings per share | $0.13 | -$1.95 | -$0.98 | -$4.12 | -$3.30 | -$2.33 |
| Free cash flow | $58.8M | $690,000 | -$32.9M | -$106.0M | -$9.1M | -$1.3M |
| Free cash margin | 14% | 0% | -7% | -14% | -1% | -0% |
| Cash | $96.3M | $87.8M | $50.7M | $33.1M | $83.2M | $82.0M |
| Long-term debt | — | — | — | $93.1M | $157.0M | $157.4M |
| Shareholders' equity | $356.9M | $336.9M | $336.9M | $598.7M | $503.1M | $450.0M |
| Shares outstanding | 19.42m | 19.84m | 20.16m | 37.16m | 38.49m | 39.83m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Mar 5, 2024 | Annual ↗ | Dec 31, 2023 | 65d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Results · Regulation FD ↗ |
| Jul 2, 2026 | Regulation FD ↗ |
| Jun 11, 2026 | Director or officer change · Shareholder vote ↗ |
| May 21, 2026 | Regulation FD ↗ |
| May 5, 2026 | Results · Regulation FD ↗ |
| Apr 9, 2026 | Results · Director or officer change ↗ |
| Feb 24, 2026 | Results · Regulation FD ↗ |
| Nov 4, 2025 | Results · Regulation FD ↗ |
| Aug 5, 2025 | Results · Regulation FD ↗ |
| Jun 20, 2025 | Shareholder vote ↗ |
| May 6, 2025 | Results · Regulation FD ↗ |
| Apr 7, 2025 | Material agreement · Agreement ended ↗ |